- Home
- ERAS vs CPZ Comparison
ERAS vs CPZ Comparison
Compare ERAS & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- CPZ
- Stock Information
- Founded
- ERAS 2018
- CPZ 2019
- Country
- ERAS United States
- CPZ United States
- Employees
- ERAS N/A
- CPZ N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- CPZ Trusts Except Educational Religious and Charitable
- Sector
- ERAS Health Care
- CPZ Finance
- Exchange
- ERAS Nasdaq
- CPZ Nasdaq
- Market Cap
- ERAS 348.4M
- CPZ 307.8M
- IPO Year
- ERAS 2021
- CPZ N/A
- Fundamental
- Price
- ERAS $1.37
- CPZ $16.06
- Analyst Decision
- ERAS Strong Buy
- CPZ
- Analyst Count
- ERAS 6
- CPZ 0
- Target Price
- ERAS $4.83
- CPZ N/A
- AVG Volume (30 Days)
- ERAS 1.7M
- CPZ 63.0K
- Earning Date
- ERAS 08-11-2025
- CPZ 01-01-0001
- Dividend Yield
- ERAS N/A
- CPZ 11.07%
- EPS Growth
- ERAS N/A
- CPZ N/A
- EPS
- ERAS N/A
- CPZ N/A
- Revenue
- ERAS N/A
- CPZ N/A
- Revenue This Year
- ERAS N/A
- CPZ N/A
- Revenue Next Year
- ERAS N/A
- CPZ N/A
- P/E Ratio
- ERAS N/A
- CPZ N/A
- Revenue Growth
- ERAS N/A
- CPZ N/A
- 52 Week Low
- ERAS $1.01
- CPZ $13.17
- 52 Week High
- ERAS $3.45
- CPZ $16.11
- Technical
- Relative Strength Index (RSI)
- ERAS 46.81
- CPZ 60.29
- Support Level
- ERAS $1.31
- CPZ $15.80
- Resistance Level
- ERAS $1.59
- CPZ $16.15
- Average True Range (ATR)
- ERAS 0.13
- CPZ 0.15
- MACD
- ERAS -0.02
- CPZ -0.01
- Stochastic Oscillator
- ERAS 25.00
- CPZ 65.12
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.